Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention

NCT03517995 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Grant not approved

Conditions

Bladder Cancer
Bladder Tumor
Urothelial Carcinoma

Interventions

DRUG: Sulforaphane Administration
OTHER: Placebo Administration
PROCEDURE: Standard of Care Surgery

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]